期刊文献+

64例脂肪变性供肝临床肝移植疗效分析 被引量:10

Liver transplantation in 64 liver donors with hepatic steatosis
原文传递
导出
摘要 目的探讨脂肪肝临床肝移植的疗效,为边缘供肝的使用提供科学依据。方法自2002年至2011年407例供肝中筛选出80例脂肪肝。其中男性69例,女性ll例。年龄20~54岁不等。80例中有16例重度脂肪变性(≥60%)供肝因合并严重灌注性损伤而予剔除,其余64例脂肪变性供肝(steatosis liver donor,SLD)按脂肪肝严重程度分为轻s1组(〈30%,n-22)、中s2组(30%~50%,n-25)、重s。组(≥600A,n=17)。随机抽取无脂肪肝80例作为so对照组。结果so组、s-组、S。组、S。组移植物早期肝功能延迟恢复发生率分别为5Voo、9.1%、20%、29.41%。S。组2例发生原发性无功能(PNF)占11.76%(2/17),占sI。D移植后PNF发生率的3.12%(2/64)。结论SLD移植后移植物早期肝功能延迟恢复的发生率以及近期并发症发生率虽较无脂肪变性者高,但不影响移植后疗效。S1~S2组移植术后1年内死亡率与SLD无相关性。重视SLD移植后并发症的处理,特别是加强术中、术后缺血再灌注损伤的防治,改善微循环,加强护肝治疗,减少近期免疫制剂用量,可取得与正常供肝同样移植疗效。 Objectives To investigate the results of liver transplantation using steatosis liver donors in order to provide a scientific basis for the use of marginal donors. Methods From 2002 to 2011, 80 of 407 were steatosis liver donors. There were 69 males and 11 females. Their age ranged from 20-54 years old. Sixteen donor livers with severe fatty liver and reperfusion injury were not used. The remaining 64 livers were divided into a S1 group (mild steatosis, n=22), a $2 group (moderate steatosis, n=25), and a $3 group (severe steatosis, n=17). A So group was used as a control (ran domly selected fat-free liver, n=80). Results The occurrence rates of delayed graft function (DGF) in the So , $1 , $2 , $3 groups were 5%, 9.1%, 20%, 29.41%, respectively. Primary nonfunctioning occurred in 2 cases of the $3 group, which represented a 11.76o/oo of the $3 group (2/17), and 3.12% of the total 64 cases (2/64). Conclusions Although the incidence rate of DGF was higher in the steatosis liver donor groups than the So group, there was no correlation in the mortality rate of the $1- $3 group within one year of transplantation. Attentions should be paid to the treatment of complica tions after steatosis liver transplantation. By minimizing ischemia-reperfusion injury, improving microcirculation, strengthening routine therapy and reducing the amount of immunosuppression, the same results could be achieved using steatosis donor liver and normal liver tor transplantation.
出处 《中华肝胆外科杂志》 CAS CSCD 北大核心 2013年第2期105-107,共3页 Chinese Journal of Hepatobiliary Surgery
关键词 肝移植 脂肪变性供肝 Liver transplantation Steatosis liver donor
  • 相关文献

参考文献9

  • 1Attia M,Silva MA,Mirza DF. The marginal liver donor:an update[J].Transplant International,2008,(8):713-724.doi:10.1111/j.1432-2277.2008.00696.x. 被引量:1
  • 2朱志军,高伟,孟醒初,张雅敏,蒋文涛,张建军,张玮晔,沈中阳.脂肪沉着供肝在肝脏移植中的应用[J].中华肝胆外科杂志,2005,11(9):627-629. 被引量:7
  • 3Chui AK,Haghighi K,Painter D. Donaor fatty (steatotic) liver allografts in orthotopic liver transplantation[J].Transplantation Proceedings,1988.3286-3287. 被引量:1
  • 4叶启发,牛英,明英姿,夏宗江,黄祖发.移植肝缺血-再灌注损伤程度的评估及其与肝移植患者预后的关系[J].中华器官移植杂志,2006,27(11):668-671. 被引量:6
  • 5Cieslak B,Lewandowski Z,Urban M. Microvesicular liver graft steatosis as a risk factor of initial poor function in relation to suboptimal donor parameters[J].Transplantation Proceedings,2009.2985-2988. 被引量:1
  • 6Verran D,Kusyk T,Painter D. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation[J].Liver Transplantation,2003,(5):500-505.doi:10.1053/jlts.2003.50099. 被引量:1
  • 7Sass DA,Reich DJ. Liver transplantation in the 21st century:expanding the donor options[J].Gastroenterology Clinics of North America,2011.641-658. 被引量:1
  • 8McCormack L,Dutkowski P. Liver transplantation using fatty livers:always feasible[J].Journal of Hepatology,2011.1055-1062. 被引量:1
  • 9Koehler E,Watt K,Charlton M. Fatty liver and liver transplantation[J].Clinics in Liver Disease,2009.621-630. 被引量:1

二级参考文献12

  • 1叶启发.Bedeutung der Messung des Sauerstoffpartialdruckes bei experimenteller Lebertransplantation[J].Journal of Huazhong University of Science and Technology(Medical Sciences),1996,16(4):234-235. 被引量:2
  • 2D'Alessandro AM, Kalayoglu M, Sollinger H, et al. The predictive value of donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation. Transplantation,1991,51: 157-163. 被引量:1
  • 3Deborab V, Taras K, Dorotby P. et al. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation. Liver Transpl,2003,9: 500-505. 被引量:1
  • 4Adam R, Reynes M, Johann M, et al. The outcome of steatotic grafts in liver transplantation. Transplant Proc, 1991,23 : 1538-1540. 被引量:1
  • 5Markin RS, Wisecarver JL, Radio SJ, et al. Frozen section evaluation of donor livers before transplantation. Transplantation, 1993,56 : 1403-1409. 被引量:1
  • 6Fishbein T, Fiel M, Emre S, et al. Use of livers with microvesicular fat safely expands the donor pool. Transplantation, 1997,64:248-251. 被引量:1
  • 7Chui A, Haghighi K, Painter D, et aL Donor fatty (steatotic)liver allografts in orthotopic liver transplantation. Transplant Proc.1999,31: 3286-3287. 被引量:1
  • 8Strasberg S, Howard T, Molmenti E, et al. Selecting the donor liver: risk factors for poor function after orthotopic liver transplantation. Hepatology, 1994,20 : 829-838. 被引量:1
  • 9Urena MA, Ruiz-Delgado FC, Gonzalez EM, et al. Assessing risk of the use of livers with macro and microsteatosis in a liver transplant program. Transplant Proc, 1998,30 : 3288-3291. 被引量:1
  • 10Rinella ME, Alonso E, Rao S, et al. Body mass index as a predictor of hepatic steatosis in living liver donors. Liver Transpl,2001,7:409-414. 被引量:1

共引文献11

同被引文献182

  • 1Tomohide Hori,Shinji Uemoto,Feng Chen,Lindsay B Gardner,Ann-Marie T Baine,Toshiyuki Hata,Takayuki Kogure,Justin H Nguyen.Oxidative stress and extracellular matrices after hepatectomy and liver transplantation in rats[J].World Journal of Hepatology,2014,6(2):72-84. 被引量:7
  • 2Yan, Sheng,Jin, Li-Ming,Liu, Yuan-Xing,Zhou, Lin,Xie, Hai-Yang,Zheng, Shu-Sen.Outcomes and mechanisms of ischemic preconditioning in liver transplantation[J].Hepatobiliary & Pancreatic Diseases International,2010,9(4):346-354. 被引量:7
  • 3朱志军,高伟,孟醒初,张雅敏,蒋文涛,张建军,张玮晔,沈中阳.脂肪沉着供肝在肝脏移植中的应用[J].中华肝胆外科杂志,2005,11(9):627-629. 被引量:7
  • 4Monbaliu D, Brassil J. Machine perfusion of the liver: past, pres- ent and future[ J ]. Curt Opin Organ Transplant, 2010,15 (2) : 160 -166. 被引量:1
  • 5Vogel T, Brockmann J G, Friend P J. Ex-vivo normothermic liver perfusion : an update [ J ]. Curt Opin Organ Transplant, 2010,15 (2) :167-172. 被引量:1
  • 6Hessheimer A J, Fondevila C, Garcia-Valdecasas JC. Extracorpo- real machine liver perfusion: are we warming up? [J]. Curr Opin Organ Transplant, 2012,17 ( 2 ) : 143-147. 被引量:1
  • 7Vogel T, Brockmann JG, Coussios C, et al. The role of normo- thermic extracorporeal perfusion in minimizing ischemia reperfusion injury[ J]. Transplant Rev (Orlando), 2012,26(2) : 156-162. 被引量:1
  • 8Clavien PA, Harvey PR, Strasberg SM. Preservation and reperfu- sion injuries in liver allografts: an overview and synthesis of cur- rent studies[ J]. Transplantation, 1992,53 (5) :957-978. 被引量:1
  • 9Carini R, Autelli R, Bellomo G, et al. Alterations of cell volume regulation in the development of hepatocyte necrosis[ J]. Exp Cell Res, 1999,248( 1 ) :280-293. 被引量:1
  • 10Starzl TE, Groth CG, Brettschneider L, et al. Extended survival in 3 cases of orthotopic homotransplantation of the human liver [J]. Surgery, 1968,63(4) :549-563. 被引量:1

引证文献10

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部